The following tables summarize the impact of the corrections of the previously mentioned errors on net income (loss) and diluted net income (loss) per share attributed to Landauer, Inc.



(Dollars in Thousands, Except per Share Amounts)	Three Months Ended June 30, 2014 (Unaudited)				Three Months Ended March 31, 2014 (Unaudited)				Three Months Ended December 31, 2013 (Unaudited)
	Net Income (Loss)		Diluted Net Income (Loss) Per Share		Net Income (Loss)		Diluted Net Income (Loss) Per Share		Net Income (Loss)		Diluted Net Income (Loss) Per Share
As previously reported	$	(36,626)	$	(3.86)	$	4,997	$	0.52	$	3,051	$	0.32
Revenue and accounts receivable		1,138				(500)				252
Dosimetry devices		13				13				12
Long-term investments		(48)				(25)				79
Sales taxes		(15)				(16)				(16)
Intangible assets		-				-				150
Equity in joint ventures		-				-				708
Total adjustments		1,088		0.11		(528)		(0.05)		1,185		0.12
Income tax expense (benefit)		805		0.08		(41)		-		403		0.04
Less amounts attributed to noncontrolling interest		(8)		-		(4)		-		12		-
Net impact of adjustments		291		0.03		(483)		(0.05)		770		0.08
As restated	$	(36,335)	$	(3.83)	$	4,514	$	0.47	$	3,821	$	0.40



(Dollars in Thousands, Except per Share Amounts)	Year Ended September 30, 2013				Three Months Ended June 30, 2013 (Unaudited)				Three Months Ended March 31, 2013 (Unaudited)
	Net Income (Loss)		Diluted Net Income (Loss) Per Share		Net Income (Loss)		Diluted Net Income (Loss) Per Share		Net Income (Loss)		Diluted Net Income (Loss) Per Share
As previously reported	$	4,836	$	0.49	$	(13,753)	$	(1.46)	$	5,153	$	0.54
Revenue and accounts receivable		(407)				(22)				-
Dosimetry devices		(177)				(44)				(44)
Long-term investments		(35)				(28)				(24)
Sales taxes		(69)				(17)				(17)
Intangible assets		50				(50)				(50)
Equity in joint ventures		(630)				(459)				(413)
Employee bonuses		(136)				-				-
Total adjustments		(1,404)		(0.15)		(620)		(0.06)		(548)		(0.06)
Income tax expense (benefit)		656		0.07		(701)		(0.07)		179		0.02
Less amounts attributed to noncontrolling interest		(6)		-		(9)		-		(4)		-
Net impact of adjustments		(2,054)		(0.22)		90		0.01		(723)		(0.08)
As restated	$	2,782	$	0.27	$	(13,663)	$	(1.45)	$	4,430	$	0.46



(Dollars in Thousands, Except per Share Amounts)	Three Months Ended December 31, 2012 (Unaudited)				Year Ended September 30, 2012
	Net Income (Loss)		Diluted Net Income (Loss) Per Share		Net Income (Loss)		Diluted Net Income (Loss) Per Share		Prior to Fiscal 2012
As previously reported	$	4,877	$	0.52	$	19,270	$	2.03
Revenue and accounts receivable		32				(211)				(1,100)
Dosimetry devices		(44)				(130)				(1,335)
Long-term investments		43				(10)				(111)
Sales taxes		(17)				(67)				(281)
Intangible assets		(50)				(200)				-
Equity in joint ventures		(471)				(78)				-
Employee bonuses		(136)				136				-
Foreign currency transaction gains & losses		-				-				316
Total adjustments		(643)		(0.07)		(560)		(0.06)		(2,511)
Income tax expense (benefit)		(30)		-		166		0.02		(640)
Less amounts attributed to noncontrolling interest		7		-		(2)		-		(49)
Net impact of adjustments		(620)		(0.07)		(724)		(0.08)	$	(1,822)
As restated (revised for fiscal 2012)	$	4,257	$	0.45	$	18,546	$	1.95

The effect of the corrections on the previously issued Consolidated Balance Sheets is as follows:



	June 30, 2014 (Unaudited)				March 31, 2014 (Unaudited)				December 31, 2013 (Unaudited)
(Dollars in Thousands)	Previously Reported		As Restated		Previously Reported		As Restated		Previously Reported		As Restated
ASSETS
Current assets:
Cash and cash equivalents	$	11,154	$	8,638	$	10,991	$	8,922	$	13,272	$	11,466
Receivables, net of allowances		34,750		34,084		35,487		34,821		34,178		33,512
Inventories		7,734		7,770		7,509		7,509		8,301		8,301
Deferred income tax asset - current		2,303		1,617		2,313		1,627		2,312		1,626
Prepaid income taxes		6,383		5,498		2,411		2,243		2,671		2,374
Prepaid expenses and other current assets		3,002		3,164		2,832		2,994		2,908		3,070
Current assets		65,326		60,771		61,543		58,116		63,642		60,349
Total property, plant and equipment, at cost		105,761		105,761		104,822		104,822		104,316		104,316
Accumulated depreciation and amortization		(57,369)		(57,369)		(55,275)		(55,275)		(53,407)		(53,407)
Net property, plant and equipment		48,392		48,392		49,547		49,547		50,909		50,909
Equity in joint ventures		23,744		23,744		23,356		23,356		22,600		22,600
Goodwill		44,645		44,645		86,384		86,384		86,529		86,529
Intangible assets, net of accumulated amortization		14,663		14,663		36,198		36,198		37,022		37,022
Dosimetry devices, net of accumulated depreciation		5,409		3,805		5,734		4,117		5,739		4,109
Other assets		20,539		24,204		7,621		10,839		7,704		10,659
ASSETS	$	222,718	$	220,224	$	270,383	$	268,557	$	274,145	$	272,177
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	5,611	$	5,611	$	6,830	$	6,830	$	6,036	$	6,036
Dividends payable		5,380		5,380		5,352		5,352		5,433		5,433
Deferred contract revenue		16,772		16,970		13,120		14,420		13,572		14,372
Accrued compensation and related costs		6,849		6,849		7,176		7,176		6,160		6,160
Other accrued expenses		7,776		8,317		6,125		6,651		6,217		6,727
Current liabilities		42,388		43,127		38,603		40,429		37,418		38,728
Non-current liabilities:
Long-term debt		138,285		138,285		138,285		138,285		143,785		143,785
Pension and postretirement obligations		13,588		13,588		13,331		13,331		13,308		13,308
Deferred income taxes		656		(1,382)		10,823		8,785		10,324		8,286
Uncertain income tax liabilities		351		3,193		529		3,283		465		3,131
Other non-current liabilities		1,067		1,067		1,221		1,221		1,425		1,425
Non-current liabilities		153,947		154,751		164,189		164,905		169,307		169,935
Commitments and Contingencies		-		-		-		-		-		-
STOCKHOLDERS’ EQUITY
Preferred stock		-		-		-		-		-		-
Common stock		962		962		963		963		962		962
Additional paid in capital		40,392		40,392		39,755		39,755		39,653		39,653
Accumulated other comprehensive loss		(4,360)		(4,318)		(4,092)		(4,098)		(4,547)		(4,578)
Retained earnings		(12,299)		(16,321)		29,606		25,293		29,582		25,752
Landauer, Inc. stockholders’ equity		24,695		20,715		66,232		61,913		65,650		61,789
Noncontrolling interest		1,688		1,631		1,359		1,310		1,770		1,725
Stockholders’ equity		26,383		22,346		67,591		63,223		67,420		63,514
LIABILITIES AND STOCKHOLDERS’ EQUITY	$	222,718	$	220,224	$	270,383	$	268,557	$	274,145	$	272,177



	September 30, 2013				June 30, 2013 (Unaudited)				March 31, 2013 (Unaudited)
(Dollars in Thousands)	Previously Reported		As Restated		Previously Reported		As Restated		Previously Reported		As Restated
ASSETS
Current assets:
Cash and cash equivalents	$	11,184	$	8,672	$	8,997	$	6,620	$	11,054	$	9,204
Receivables, net of allowances		38,419		37,839		34,807		34,328		36,419		35,940
Inventories		9,539		9,729		9,487		9,739		9,718		9,718
Deferred income tax asset - current		2,312		1,626		2,259		1,644		2,339		1,724
Prepaid income taxes		3,132		3,270		3,513		4,403		4,902		4,976
Prepaid expenses and other current assets		1,707		1,869		2,259		2,421		1,928		1,928
Current assets		66,293		63,005		61,322		59,155		66,360		63,490
Total property, plant and equipment cost		107,446		107,446		106,248		106,248		105,883		105,883
Accumulated depreciation and amortization		(55,514)		(55,514)		(53,326)		(53,326)		(51,256)		(51,256)
Net property, plant and equipment		51,932		51,932		52,922		52,922		54,627		54,627
Equity in joint ventures		23,942		23,234		22,735		21,314		22,683		21,721
Goodwill		84,436		84,436		83,833		83,833		106,746		106,746
Intangible assets, net of accumulated amortization		37,161		37,011		37,987		37,637		36,091		35,791
Dosimetry devices, net of accumulated depreciation		5,798		4,156		6,221		4,624		6,436		4,883
Other assets		7,271		10,932		5,837		9,261		6,101		9,058
ASSETS	$	276,833	$	274,706	$	270,857	$	268,746	$	299,044	$	296,316
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	6,310	$	6,310	$	5,490	$	5,490	$	6,541	$	6,541
Dividends payable		5,419		5,419		5,389		5,389		5,403		5,403
Deferred contract revenue		13,181		14,509		13,572		14,646		14,413		15,213
Accrued compensation and related costs		8,207		8,207		7,146		7,146		6,938		6,938
Other accrued expenses		7,531		8,025		8,863		9,308		7,789		8,217
Current liabilities		40,648		42,470		40,460		41,979		41,084		42,312
Non-current liabilities:
Long-term debt		142,785		142,785		139,560		139,560		143,260		143,260
Pension and postretirement obligations		13,047		13,047		17,655		17,655		17,821		17,821
Deferred income taxes		9,817		7,899		10,118		8,096		16,179		14,159
Uncertain income tax liabilities		625		3,203		621		2,963		840		2,963
Other non-current liabilities		290		290		271		271		266		266
Non-current liabilities		166,564		167,224		168,225		168,545		178,366		178,469
Commitments and Contingencies		-		-		-		-		-		-
STOCKHOLDERS’ EQUITY
Preferred stock		-		-		-		-		-		-
Common stock		958		958		959		959		956		956
Additional paid in capital		39,465		39,465		39,034		39,034		37,063		37,063
Accumulated other comprehensive loss		(4,456)		(4,408)		(7,866)		(7,960)		(7,324)		(7,446)
Retained earnings		32,012		27,412		28,721		24,922		47,685		43,796
Landauer, Inc. stockholders’ equity		67,979		63,427		60,848		56,955		78,380		74,369
Noncontrolling interest		1,642		1,585		1,324		1,267		1,214		1,166
Stockholders’ equity		69,621		65,012		62,172		58,222		79,594		75,535
LIABILITIES AND STOCKHOLDERS’ EQUITY	$	276,833	$	274,706	$	270,857	$	268,746	$	299,044	$	296,316



	December 31, 2012 (Unaudited)				September 30, 2012
(Dollars in Thousands)	Previously Reported		As Restated		Previously Reported		As Revised
ASSETS
Current assets:
Cash and cash equivalents	$	16,497	$	14,927	$	17,633	$	15,675
Receivables, net of allowances		36,391		35,912		35,165		34,686
Inventories		9,199		9,199		8,638		8,725
Deferred income tax asset - current		2,473		1,858		2,414		1,799
Prepaid income taxes		698		836		2,148		2,141
Prepaid expenses and other current assets		2,015		2,015		1,561		1,561
Current assets		67,273		64,747		67,559		64,587
Total property, plant and equipment cost		103,330		103,330		101,375		101,375
Accumulated depreciation and amortization		(49,125)		(49,125)		(46,983)		(46,983)
Net property, plant and equipment		54,205		54,205		54,392		54,392
Equity in joint ventures		22,664		22,115		24,108		24,030
Goodwill		107,001		107,001		106,717		106,717
Intangible assets, net of accumulated amortization		36,793		36,543		37,402		37,202
Dosimetry devices, net of accumulated depreciation		6,537		5,028		6,189		4,724
Other assets		6,366		8,941		5,758		8,619
ASSETS	$	300,839	$	298,580	$	302,125	$	300,271
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	6,637	$	6,637	$	9,656	$	9,656
Dividends payable		5,342		5,342		5,345		5,345
Deferred contract revenue		15,065		15,865		14,947		15,866
Accrued compensation and related costs		5,520		5,520		8,260		8,124
Other accrued expenses		7,215		7,626		7,096		7,490
Current liabilities		39,779		40,990		45,304		46,481
Non-current liabilities:
Long-term debt		145,847		145,847		141,347		141,347
Pension and postretirement obligations		17,690		17,690		17,586		17,586
Deferred income taxes		15,745		13,727		15,733		13,717
Uncertain income tax liabilities		672		2,576		667		2,352
Other non-current liabilities		326		326		386		386
Non-current liabilities		180,280		180,166		175,719		175,388
Commitments and Contingencies		-		-		-		-
STOCKHOLDERS’ EQUITY
Preferred stock		-		-		-		-
Common stock		955		955		949		949
Additional paid in capital		36,587		36,587		35,898		35,898
Accumulated other comprehensive loss		(5,788)		(5,934)		(5,272)		(5,375)
Retained earnings		47,793		44,627		48,142		45,596
Landauer, Inc. stockholders’ equity		79,547		76,235		79,717		77,068
Noncontrolling interest		1,233		1,189		1,385		1,334
Stockholders’ equity		80,780		77,424		81,102		78,402
LIABILITIES AND STOCKHOLDERS’ EQUITY	$	300,839	$	298,580	$	302,125	$	300,271

The effect of the corrections on the previously issued Consolidated Statements of Operations is as follows:



	Three Months Ended June 30, 2014 (Unaudited)				Three Months Ended March 31, 2014 (Unaudited)				Three Months Ended December 31, 2013 (Unaudited)
(Dollars in Thousands, Except per Share)	Previously Reported		As Restated		Previously Reported		As Restated		Previously Reported		As Restated
Service revenues	$	31,013	$	31,800	$	32,983	$	32,870	$	31,894	$	31,745
Product revenues		3,753		4,068		6,571		6,184		5,811		6,402
Net revenues		34,766		35,868		39,554		39,054		37,705		38,147
Costs and expenses:
Service costs		16,149		16,109		15,195		15,155		15,049		15,010
Product costs		1,830		1,821		3,150		3,177		3,158		3,375
Total cost of sales		17,979		17,930		18,345		18,332		18,207		18,385
Gross profit		16,787		17,938		21,209		20,722		19,498		19,762
Selling, general, and administrative		13,805		13,819		13,735		13,750		14,362		14,226
Goodwill impairment charge		62,188		62,188		-		-		-		-
Acquisition, reorganization and nonrecurring costs		1,558		1,558		109		109		111		111
Operating income		(60,764)		(59,627)		7,365		6,863		5,025		5,425
Equity in income of joint ventures		256		256		535		535		573		1,281
Interest expense, net		(817)		(867)		(975)		(1,014)		(892)		(937)
Other income (expense), net		(22)		(21)		(8)		5		37		159
Income before taxes		(61,347)		(60,259)		6,917		6,389		4,743		5,928
Income tax (benefit) expense		(25,030)		(24,225)		1,954		1,913		1,496		1,899
Net income		(36,317)		(36,034)		4,963		4,476		3,247		4,029
Less: Net income attributed to noncontrolling interest		309		301		(34)		(38)		196		208
Net income attributed to Landauer, Inc.	$	(36,626)	$	(36,335)	$	4,997	$	4,514	$	3,051	$	3,821
Net income per share attributed to Landauer, Inc. shareholders:
Basic	$	(3.86)	$	(3.83)	$	0.52	$	0.47	$	0.32	$	0.40
Weighted average basic shares outstanding		9,482		9,482		9,460		9,460		9,422		9,422
Diluted	$	(3.86)	$	(3.83)	$	0.52	$	0.47	$	0.32	$	0.40
Weighted average diluted shares outstanding		9,482		9,482		9,501		9,501		9,467		9,467



	Year Ended September 30, 2013				Three Months Ended June 30, 2013 (Unaudited)				Three Months Ended March 31, 2013 (Unaudited)
(Dollars in Thousands, Except per Share)	Previously Reported		As Restated		Previously Reported		As Restated		Previously Reported		As Restated
Service revenues	$	126,840	$	126,528	$	31,591	$	31,538	$	32,533	$	32,480
Product revenues		23,360		23,162		4,989		4,768		4,549		4,602
Net revenues		150,200		149,690		36,580		36,306		37,082		37,082
Costs and expenses:
Service costs		59,859		59,931		15,474		15,492		14,863		14,881
Product costs		11,161		11,163		2,490		2,264		2,187		2,213
Total cost of sales		71,020		71,094		17,964		17,756		17,050		17,094
Gross profit		79,180		78,596		18,616		18,550		20,032		19,988
Selling, general, and administrative		50,968		51,115		12,550		12,615		12,578		12,643
Goodwill impairment charge		22,700		22,700		22,700		22,700		-		-
Acquisition, reorganization and nonrecurring costs		1,392		1,392		142		142		300		300
Operating income		4,120		3,389		(16,776)		(16,907)		7,154		7,045
Equity in income of joint ventures		3,881		3,251		471		12		556		143
Interest expense, net		(4,184)		(4,311)		(1,154)		(1,185)		(1,081)		(1,107)
Other income (expense), net		663		747		112		113		224		224
Income before taxes		4,480		3,076		(17,347)		(17,967)		6,853		6,305
Income tax (benefit) expense		(1,216)		(560)		(3,748)		(4,449)		1,620		1,799
Net income		5,696		3,636		(13,599)		(13,518)		5,233		4,506
Less: Net income attributed to noncontrolling interest		860		854		154		145		80		76
Net income attributed to Landauer, Inc.	$	4,836	$	2,782	$	(13,753)	$	(13,663)	$	5,153	$	4,430
Net income per share attributed to Landauer, Inc. shareholders:
Basic	$	0.50	$	0.28	$	(1.46)	$	(1.45)	$	0.54	$	0.46
Weighted average basic shares outstanding		9,434		9,434		9,439		9,439		9,417		9,417
Diluted	$	0.49	$	0.27	$	(1.46)	$	(1.45)	$	0.54	$	0.46
Weighted average diluted shares outstanding		9,482		9,482		9,439		9,439		9,462		9,462



	Three Months Ended December 31, 2012 (Unaudited)				Year Ended September 30, 2012
(Dollars in Thousands, Except per Share)	Previously Reported		As Restated		Previously Reported		As Revised
Service revenues	$	31,469	$	31,416	$	124,979	$	124,800
Product revenues		5,212		5,384		27,421		27,302
Net revenues		36,681		36,800		152,400		152,102
Costs and expenses:
Service costs		14,308		14,326		53,489		53,619
Product costs		2,255		2,368		11,903		11,816
Total cost of sales		16,563		16,694		65,392		65,435
Gross profit		20,118		20,106		87,008		86,667
Selling, general, and administrative		13,391		13,592		51,096		51,218
Acquisition, reorganization and nonrecurring costs		-		-		4,299		4,299
Abandonment charges		-		-		3,443		3,443
Operating income		6,727		6,514		28,170		27,707
Equity in income of joint ventures		1,528		1,057		3,181		3,103
Interest expense, net		(1,033)		(1,065)		(3,308)		(3,435)
Other income (expense), net		95		168		97		205
Income before taxes		7,317		6,674		28,140		27,580
Income tax (benefit) expense		2,274		2,244		8,040		8,206
Net income		5,043		4,430		20,100		19,374
Less: Net income attributed to noncontrolling interest		166		173		830		828
Net income attributed to Landauer, Inc.	$	4,877	$	4,257	$	19,270	$	18,546
Net income per share attributed to Landauer, Inc. shareholders:
Basic	$	0.52	$	0.45	$	2.04	$	1.96
Weighted average basic shares outstanding		9,336		9,336		9,389		9,389
Diluted	$	0.52	$	0.45	$	2.03	$	1.95
Weighted average diluted shares outstanding		9,385		9,385		9,437		9,437

The effect of the corrections on the previously issued Consolidated Statements of Cash Flows is as follows:



	Nine Months Ended June 30, 2014 (Unaudited)				Six Months Ended March 31, 2014 (Unaudited) (a)				Three Months Ended December 31, 2013 (Unaudited) (a)
(Dollars in Thousands)	Previously Reported		As Restated		Previously Reported		As Restated		Previously Reported		As Restated
Cash flows provided from operating activities:
Net income (loss)	$	(28,107)	$	(27,529)	$	8,210	$	8,505	$	3,247	$	4,029
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		11,607		11,419		7,662		7,487		3,894		3,732
Goodwill and other intangible assets impairment charge		62,188		62,188		-		-		-		-
Gain on sale, disposal and abandonment of assets		(35)		(35)		-		-		-		-
Gain on investments		(369)		(505)		(203)		(338)		(146)		(268)
Equity in income of joint ventures		(1,364)		(2,072)		(1,108)		(1,816)		(573)		(1,281)
Dividends from joint ventures		1,340		1,340		1,340		1,340		1,340		1,340
Stock-based compensation and related net tax benefits		1,066		1,066		453		453		282		282
Current and long-term deferred taxes, net		(21,973)		(21,829)		791		847		292		260
Changes in operating assets and liabilities:
Decrease in accounts receivable, net		3,815		3,901		3,119		3,205		4,396		4,482
(Increase) decrease in prepaid taxes		(3,247)		(2,224)		721		1,027		466		901
(Increase) decrease in other operating assets, net		(227)		(73)		571		761		(88)		102
(Decrease) increase in accounts payable and other accrued liabilities		1,379		296		(2,025)		(2,021)		(3,328)		(3,840)
Increase in other operating liabilities, net		608		608		430		430		200		200
Net cash provided by operating activities		26,681		26,551		19,961		19,880		9,982		9,939
Cash flows used by investing activities:
Acquisition of property, plant & equipment		(3,056)		(3,056)		(2,415)		(2,415)		(1,245)		(1,245)
Acquisition of joint ventures and businesses, net of cash acquired		(1,800)		(1,800)		(1,800)		(1,800)		(1,800)		(1,800)
Other investing activities, net		(1,037)		(855)		(637)		(114)		(573)		97
Net cash used by investing activities		(5,893)		(5,711)		(4,852)		(4,329)		(3,618)		(2,948)
Cash flows (used) provided by financing activities:
Net borrowings on revolving credit facility		(51)		(51)		(43)		(43)		(21)		(21)
Long–term borrowings - loan		27,500		27,500		20,000		20,000		14,000		14,000
Long–term borrowings - repayment		(32,000)		(32,000)		(24,500)		(24,500)		(13,000)		(13,000)
Dividends paid to stockholders		(15,771)		(15,771)		(10,520)		(10,520)		(5,274)		(5,274)
Other financing activities, net		(500)		(500)		(347)		(347)		49		49
Net cash (used) provided by financing activities		(20,822)		(20,822)		(15,410)		(15,410)		(4,246)		(4,246)
Effects of foreign currency translation		4		(52)		108		109		(30)		49
Net (decrease) increase in cash and cash equivalents		(30)		(34)		(193)		250		2,088		2,794
Opening balance – cash and cash equivalents		11,184		8,672		11,184		8,672		11,184		8,672
Ending balance – cash and cash equivalents	$	11,154	$	8,638	$	10,991	$	8,922	$	13,272	$	11,466



	Year Ended September 30, 2013 (a)				Nine Months Ended June 30, 2013 (Unaudited) (a)				Six Months Ended March 31, 2013 (Unaudited)
(Dollars in Thousands)	Previously Reported		As Restated		Previously Reported		As Restated		Previously Reported		As Restated
Cash flows provided from operating activities:
Net income	$	5,696	$	3,636	$	(3,323)	$	(4,582)	$	10,276	$	8,936
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		14,924		15,051		10,860		11,142		6,976		7,164
Goodwill impairment charge		22,700		22,700		22,700		22,700		-		-
Gain on sale, disposal and abandonment of assets		(32)		(32)		-		-		-		-
Gain on investments		(282)		(366)		(118)		(192)		-		(73)
Equity in income of joint ventures		(3,881)		(3,251)		(2,555)		(1,212)		(2,084)		(1,200)
Dividends from joint ventures		1,891		1,891		1,891		1,891		1,891		1,891
Stock-based compensation and related net tax benefits		2,541		2,541		2,293		2,293		1,504		1,504
Current and long-term deferred taxes, net		(5,858)		(4,680)		(5,531)		(4,880)		284		718
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable, net		(3,113)		(3,012)		305		305		(1,244)		(1,244)
Increase in prepaid taxes		(985)		(1,130)		(1,349)		(2,246)		(2,755)		(2,836)
Increase in other operating assets, net		(4,036)		(4,547)		(3,479)		(3,950)		(2,839)		(2,956)
(Decrease) increase in accounts payable and other accrued liabilities		(596)		49		(1,157)		(815)		(2,959)		(2,908)
Decrease in other operating liabilities, net		(3,501)		(3,501)		(1,073)		(1,073)		(26)		(26)
Net cash provided by operating activities		25,468		25,349		19,464		19,381		9,024		8,970
Cash flows used by investing activities:
Acquisition of property, plant & equipment		(9,145)		(9,145)		(8,135)		(8,135)		(5,962)		(5,962)
Acquisition of joint ventures and businesses, net of cash acquired		-		-		-		-		-		-
Other investing activities, net		(1,869)		(2,534)		(1,855)		(2,355)		(678)		(513)
Net cash used by investing activities		(11,014)		(11,679)		(9,990)		(10,490)		(6,640)		(6,475)
Cash flows (used) provided by financing activities:
Net borrowings on revolving credit facility		(19)		(19)		-		-		-		-
Long–term borrowings - loan		27,691		27,691		19,600		19,600		10,300		10,300
Long–term borrowings - repayment		(27,187)		(27,187)		(21,387)		(21,387)		(8,587)		(8,587)
Dividends paid to stockholders		(20,897)		(20,897)		(15,658)		(15,658)		(10,429)		(10,429)
Other financing activities, net		(261)		(261)		(460)		(460)		(260)		(260)
Net cash (used) provided by financing activities		(20,673)		(20,673)		(17,905)		(17,905)		(8,976)		(8,976)
Effects of foreign currency translation		(230)		-		(205)		(41)		13		10
Net (decrease) increase in cash and cash equivalents		(6,449)		(7,003)		(8,636)		(9,055)		(6,579)		(6,471)
Opening balance – cash and cash equivalents		17,633		15,675		17,633		15,675		17,633		15,675
Ending balance – cash and cash equivalents	$	11,184	$	8,672	$	8,997	$	6,620	$	11,054	$	9,204